Pivot Park and Aspen Oss, both located in Oss and neighbours of each other, have signed an important letter of intent for the development and lease of the Hodgkin building, commonly known as “Panther”, at Pivot Park by Aspen Oss. Together, they will further explore how the interior should be laid out and whether they can reach agreement on this. The planned collaboration underlines the strengthening of the pharmaceutical cluster in Oss.

This step will enable Aspen Oss and its sister company BioChem Oss to cluster all laboratory activities currently carried out in various buildings at the Moleneind site in Oss. “The new, state-of-the-art building on the Pivot Park site offers modern facilities for both laboratory and office functions, and thus fits in seamlessly with the ambitions of Aspen Oss and BioChem Oss. The building complies with all industrial hygiene and safety regulations as well as GMP requirements, and has been designed with future-proofing and sustainability in mind, meeting the highest standards of energy efficiency. This also strengthens our attractiveness as a partner to customers and to new and existing talent,” says Marcel Broecks (Site Director Aspen Oss).

Expansion of ecosystem

Pivot Park is delighted with the intention to work more closely with Aspen Oss. “Due to circumstances, Panther has been waiting for some time to be put into use. We are therefore particularly pleased to have signed the letter of intent together with this partner within the Oss pharma cluster. This will enable us to start designing and setting up the facility. In doing so, we are strengthening the ecosystem that is so important for a campus like Pivot Park,” said Brigitte Drees (CEO Pivot Park).

The exploration of Panther’s layout will run until the end of August 2025, with the aim of having the first employees move into the building in June 2027. The first appointments to set this process in motion have already been scheduled.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?

#100YEARSPHARMAFUTURE

The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.